Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-26T04:53:55.223Z Has data issue: false hasContentIssue false
  • English
  • Français

Ziprasidone and Hypomania

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
CNS Spectrums , Volume 10 , Issue 8 , August 2005 , pp. 606
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Crane, DL. Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders. CNS Spectr. 2005;10:176–179.Google Scholar
2.Baldassano, CF, Ballas, C, Datto, SM, et al.Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord. 2003;5:72–75.Google Scholar
3.Keating, AM, Aoun, SL, Dean, CE. Ziprasidone-associated mania: a review and report of 2 additional cases. Clin Neuropharmacol. 2005;28:83–86.CrossRefGoogle Scholar
4.Davis, R, Risch, SC. Ziprasidone induction of hypomania in depression? Am J Psychiatry. 2002;159:673–674.Google Scholar
5.Privitera, MR, Maharaj, K. Mania form dose-related ziprasidone augmentation of an SSRI. J Clin Psychiatry. 2003;64:1393–1394.Google Scholar